Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00909480

Public ClinicalTrials.gov record NCT00909480. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 5:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 26 Week Randomised, Multinational, Open Labelled, 2 Armed, Parallel Group, Treat-to-target Once Daily Treatment Trial With Insulin Detemir Versus Insulin Glargine, Both in Combination With Metformin in Subjects With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Asia, South America and the United States of America (USA). The aim of this clinical trial is to determine whether two insulin treatments given once daily are equally effective with respect to the blood glucose lowering effect in subjects with type 2 diabetes inadequately controlled on metformin treatment with or without an additional anti-diabetic drug (OAD).

Study identification

NCT ID
NCT00909480
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
457 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2009 (Type not available)
Primary completion
Jun 2010 (Actual)
Completion
Jun 2010 (Actual)
Last update posted
Mar 10, 2017

2009 – 2010

United States locations

U.S. sites
71
U.S. states
29
U.S. cities
66
Facility City State ZIP Site status
Novo Nordisk Investigational Site Litchfield Park Arizona 85340 —
Novo Nordisk Investigational Site Searcy Arkansas 72143 —
Novo Nordisk Investigational Site Anaheim California 92801 —
Novo Nordisk Investigational Site Concord California 94520 —
Novo Nordisk Investigational Site Escondido California 92025 —
Novo Nordisk Investigational Site Fresno California 93720 —
Novo Nordisk Investigational Site Long Beach California 90822 —
Novo Nordisk Investigational Site Los Angeles California 90057 —
Novo Nordisk Investigational Site Redlands California 92374 —
Novo Nordisk Investigational Site Santa Ana California 92705 —
Novo Nordisk Investigational Site Spring Valley California 91978 —
Novo Nordisk Investigational Site Aurora Colorado 80045 —
Novo Nordisk Investigational Site Norwalk Connecticut 06851 —
Novo Nordisk Investigational Site Hollywood Florida 33021 —
Novo Nordisk Investigational Site Jacksonville Florida 32204 —
Novo Nordisk Investigational Site Jacksonville Florida 32207 —
Novo Nordisk Investigational Site Miami Florida 33136 —
Novo Nordisk Investigational Site Miami Florida 33143 —
Novo Nordisk Investigational Site Ocala Florida 34471 —
Novo Nordisk Investigational Site Orlando Florida 32804 —
Novo Nordisk Investigational Site Plantation Florida 33324 —
Novo Nordisk Investigational Site Ponte Vedra Florida 32081 —
Novo Nordisk Investigational Site Winter Haven Florida 33880 —
Novo Nordisk Investigational Site Powder Springs Georgia 30127 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596 —
Novo Nordisk Investigational Site Independence Kansas 67301-3263 —
Novo Nordisk Investigational Site Shawnee Mission Kansas 66204 —
Novo Nordisk Investigational Site Portland Maine 04101 —
Novo Nordisk Investigational Site Rockville Maryland 20852 —
Novo Nordisk Investigational Site Waltham Massachusetts 02453 —
Novo Nordisk Investigational Site Buckley Michigan 49620 —
Novo Nordisk Investigational Site Chesterfield Missouri 63017 —
Novo Nordisk Investigational Site Jefferson City Missouri 65109 —
Novo Nordisk Investigational Site St Louis Missouri 63141 —
Novo Nordisk Investigational Site Butte Montana 59701 —
Novo Nordisk Investigational Site Clilfton New Jersey 07011 —
Novo Nordisk Investigational Site Northport New York 11768 —
Novo Nordisk Investigational Site Staten Island New York 10301 —
Novo Nordisk Investigational Site Syracuse New York 13210 —
Novo Nordisk Investigational Site Charlotte North Carolina 28277 —
Novo Nordisk Investigational Site Greensboro North Carolina 27408 —
Novo Nordisk Investigational Site Winston-Salem North Carolina 27103 —
Novo Nordisk Investigational Site Cayahoga Falls Ohio 44223 —
Novo Nordisk Investigational Site Cincinnati Ohio 45245 —
Novo Nordisk Investigational Site Dayton Ohio 45406 —
Novo Nordisk Investigational Site Gallipolis Ohio 45631-1560 —
Novo Nordisk Investigational Site Tulsa Oklahoma 74104 —
Novo Nordisk Investigational Site Altoona Pennsylvania 16602 —
Novo Nordisk Investigational Site Clarion Pennsylvania 16214 —
Novo Nordisk Investigational Site Lancaster Pennsylvania 17601 —
Novo Nordisk Investigational Site Norristown Pennsylvania 19401 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19104 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107 —
Novo Nordisk Investigational Site Greer South Carolina 29651 —
Novo Nordisk Investigational Site Spartanburg South Carolina 29303 —
Novo Nordisk Investigational Site Taylors South Carolina 29687 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37404 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37411 —
Novo Nordisk Investigational Site Corpus Christi Texas 78404 —
Novo Nordisk Investigational Site Dallas Texas 75230 —
Novo Nordisk Investigational Site Dallas Texas 75246 —
Novo Nordisk Investigational Site Houston Texas 77025 —
Novo Nordisk Investigational Site Hurst Texas 76054 —
Novo Nordisk Investigational Site Odessa Texas 79761 —
Novo Nordisk Investigational Site San Antonio Texas 78209 —
Novo Nordisk Investigational Site St. George Utah 84790 —
Novo Nordisk Investigational Site Virginia Beach Virginia 23462 —
Novo Nordisk Investigational Site Renton Washington 98057 —
Novo Nordisk Investigational Site Martinsburg West Virginia 25401 —
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00909480, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 10, 2017 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00909480 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →